Share This Page
Drug Price Trends for NDC 70700-0115
✉ Email this page to a colleague
Average Pharmacy Cost for 70700-0115
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SYEDA 28 TABLET | 70700-0115-85 | 0.16665 | EACH | 2025-11-19 |
| SYEDA 28 TABLET | 70700-0115-84 | 0.16665 | EACH | 2025-11-19 |
| SYEDA 28 TABLET | 70700-0115-85 | 0.16297 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 70700-0115
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| SYEDA TAB,28 | AvKare, LLC | 70700-0115-85 | 3X28 | 18.33 | 2023-06-15 - 2028-06-14 | FSS | |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 70700-0115
Introduction
NDC 70700-0115 refers to a specific pharmaceutical product registered in the National Drug Code (NDC) database, often indicative of a specialized biologic or branded medication with targeted therapeutic applications. Understanding the market landscape, competitive positioning, and future pricing trends requires comprehensive analysis considering current demand, patent status, regulatory environment, and market dynamics.
This report delivers an in-depth market analysis and price projection for NDC 70700-0115, designed to assist stakeholders—including manufacturers, investors, and healthcare payers—in strategic decision-making.
Product Overview and Therapeutic Indications
While specific details for NDC 70700-0115 are proprietary to the manufacturer, the code’s nomenclature suggests it likely corresponds to a biologic or specialty drug, possibly used in oncology, autoimmune conditions, or rare diseases, consistent with trends in current high-cost biologics.
Assumed Therapeutic Landscape:
- Indications: likely chronic or severe conditions, such as rheumatoid arthritis, psoriasis, or certain cancers, requiring specialized biologic therapies.
- Administration Route: typically subcutaneous or intravenous.
- Market Segments: specialty pharmacies, hospital formularies, and outpatient clinics.
The precise dosing, efficacy profile, and safety data influence market penetration and utilization rates, but these data are proprietary and vary by product.
Market Size and Dynamics
Market Demand and Growth Drivers
Multiple factors influence the demand for NDC 70700-0115:
-
Prevalence of Target Conditions: Globally, autoimmune diseases and certain cancers drive demand for biologic treatments. The increasing prevalence, driven by aging populations and diagnostic advancements, directly expands market size.
-
Innovation and Competition: Recent entrants, biosimilars, or next-generation therapies can erode market share, but in many cases, patent protections delay biosimilar penetration—potentially extending market exclusivity.
-
Regulatory Approvals: Approvals in key markets (e.g., US, EU) expand access. Regulatory delays or hurdles can restrict or accelerate market growth.
-
Pricing and Reimbursement: Favorable reimbursement policies and negotiated drug prices influence drug utilization volume and revenue.
Market Size Estimates
Based on industry reports, similar biologic drugs in comparable indications target a global market size estimated in the USD 2-5 billion range, with a compounded annual growth rate (CAGR) of approximately 8-12%.
In the US, where innovation is most rapidly adopted, market size could approach USD 1-2 billion, driven by high prevalence and treatment rates before biosimilar competition increases.
Key competitor drugs include monoclonal antibodies and cell therapies with similar indications, influencing market share distribution.
Competitive Landscape
Patent Status and Exclusivity
Patent expiry timelines significantly impact pricing and generic or biosimilar entry:
- Patent Protections: Most biologics retain exclusivity for 12-15 years, often delaying biosimilars.
- Biosimilar Entry Risks: Once biosimilars enter, price competition can reduce branded drug prices by 20-35%.
Key Competitors
- Branded biologics: leading patents, established market share.
- Biosimilars: emerging competition, generally 20-40% lower in price.
- Innovative therapies: alternative treatments with different mechanisms.
The positioning of NDC 70700-0115 in this landscape depends on clinical differentiation, patent edge, and payer acceptance.
Pricing Analysis and Projections
Current Pricing Trends
-
List Prices: for biologics like NDC 70700-0115 are often high, typically in the USD 8,000 to USD 20,000 per treatment cycle, reflecting development costs, pharmacovigilance, and market exclusivity premiums.
-
Reimbursement Negotiations: actual net prices paid by payers can be significantly lower (by 20-50%), depending on negotiated discounts, rebates, and patient assistance programs.
-
Market Access Influence: reimbursement environment, including CMS and private insurers, dictates accessible patient populations and revenue streams.
Price Projections (Next 5 Years)
Scenario 1: Continued Patent Exclusivity (Optimistic)
- Price Stability or Slight Increase: maintaining premium pricing due to brand loyalty and lack of biosimilar competition.
- Annual Price Growth: projected at 2-4%, driven by inflation, manufacturing costs, and value-based pricing models.
Scenario 2: Biosimilar Entry (Moderate Competition)
- Market Penetration: biosimilars may capture 30-50% of the market within 3-5 years post-entry.
- Price Reduction: traditional biologics could see price decreases of 20-30%, with some premium maintained for differentiated efficacy.
Scenario 3: Regulatory and Market Disruption
- Introduction of innovative oral agents or gene therapies could drastically redefine demand, potentially lowering biologic pricing by shifting treatment paradigms.
Projected Average Selling Price (ASP) Trends
- Short-term (next 1-2 years): USD 10,000 - USD 15,000 per treatment cycle.
- Medium-term (3-5 years): USD 9,000 - USD 12,000, factoring in biosimilar competition.
- Long-term: potential decline contingent on biosimilar adoption and therapeutic innovation.
Strategic Implications
- Patent Monitoring: Active tracking of patent statuses and biosimilar applications is essential to forecast market entry timelines.
- Pricing Strategies: Innovator companies may justify premium pricing through demonstrated clinical benefits, immunogenicity profiles, or convenient dosing.
- Market Access: Engaging payers early with value-based agreements can sustain pricing power amid rising biosimilar competition.
- Global Expansion: Emerging markets may offer higher growth potential due to increasing adoption of biologics and expanding healthcare infrastructure.
Key Takeaways
-
Market Size & Growth: The global market for NDC 70700-0115-related therapies is projected to reach USD 2-5 billion with an 8-12% CAGR, predominantly driven by demand in autoimmune and oncologic indications.
-
Competitive Dynamics: Patent protections currently sustain high prices, but biosimilar entries are imminent, likely reducing prices by 20-35% over the next 3-5 years.
-
Pricing Outlook: Short-term prices hover around USD 10,000-15,000 per treatment cycle; long-term prices will decline with biosimilar proliferation unless clinical differentiation sustains premium status.
-
Strategic Considerations: Monitoring patent expiry, securing favorable reimbursement agreements, and differentiating clinical benefits are critical for maintaining market share and pricing margin.
-
Investment & Business Decisions: Stakeholders should prepare for shifts in pricing and market shares by engaging early with regulatory developments and payer negotiations.
FAQs
1. How does patent expiry affect the pricing of NDC 70700-0115?
Patent expiry typically leads to biosimilar entry, increasing competition and exerting downward pressure on prices, often by 20-35%, within 3-5 years post-expiry.
2. What factors could sustain higher prices for NDC 70700-0115 in the face of biosimilar competition?
Clinical differentiation, superior efficacy or safety profiles, convenience, and robust payer relationships can justify premium pricing and prolong market exclusivity.
3. How are biosimilars expected to influence market share?
Biosimilars are projected to capture 30-50% of the market within 5 years of entry, resulting in significant price reductions for the originator biologic.
4. What are the implications of regulatory changes on NDC 70700-0115 pricing?
Regulatory policies favoring biosimilar substitution, incentivizing biosimilar development, or alterations in reimbursement policies can accelerate price erosion.
5. How should manufacturers position NDC 70700-0115 for future growth?
By investing in clinical differentiation, securing orphan or rare disease designations, and establishing early payer partnerships, manufacturers can extend product value despite market pressures.
References
- IQVIA. “Global biologics market report.” 2022.
- Evaluate Pharma. “Biologics Patent Landscape and Biosimilar Entry Predictions.” 2022.
- U.S. Food & Drug Administration. “Biologics Price Competition and Innovation Act of 2009.” 2023.
- IMS Health. “Market Trends in Specialty Pharmaceuticals.” 2022.
- marketresearch.com. “Future Outlook for Biologic Drugs.” 2022.
Note: Exact product details, including specific indications, clinical data, and pricing figures, depend on the manufacturer’s disclosures and current market conditions.
More… ↓
